Z-2382-2021Class II
EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128
Theratest Laboratories, Inc. / initiated 2020-10-05 / Terminated
Thera Test Laboratories, Inc. began a recall of EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128 on . FDA classified it as Class II and gives the reason as "The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128". As of , the recall status on record is Terminated.
Recall record
- Recall number
- Z-2382-2021
- Classification
- Class II
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Theratest Laboratories, Inc.
- Product
- EL-Anti-SARS-CoV-2 IgG Kit, Catalog #104-130. Submitted as EUA202128
- Product code
- QKO Reagent, Coronavirus Serological
- Reason for recall
- The cross-reactivity of the device may present an increased level of potential false positives. Submitted as EUA202128
- FDA root cause
- No Marketing Application
- Action
- The firm initiated the recall using undated letters attached to emails sent on 10/7/2020 requesting return of product.
- Quantity in commerce
- 19 kits
- Distribution
- US Nationwide distribution in the states of California, Florida, Illinois, Indiana, North Carolina, and Texas.
- Product codes and lots
- Lot numbers 05204351, exp. 5/1/2021, and 05204368, exp. 05/19/2021.
Enforcement reports
One row per recalled product line| Recall number | Class | Status | Voluntary or mandated | Report date | Classified |
|---|---|---|---|---|---|
| Z-2382-2021 | Class II | Terminated | Voluntary: Firm initiated |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
